
Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search
The sponsor (pharmaceutical company) of this product has
advised Medsafe that this product has either been discontinued or is no longer
marketed in New Zealand.
Therefore this CMI may not be up to date.
Medsafe has elected to leave it on this web site because supplies of this
product may still be available, and consumers should continue to have access
to this product information in the interim.
You may be able to find a more current CMI containing the same medicine by
returning to the main CMI page and searching by ingredient name.
This leaflet answers some common questions about Aredia.
It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you having
Aredia against the benefits they expect it will provide.
If you have any concerns about this medicine, ask your doctor or pharmacist.
Keep this leaflet. You may need to read it again.
Aredia is used to lower the amount of calcium in the blood when it becomes too high, as may happen in some forms of cancer.
Some cancers can speed up normal changes in bone so that the amount of calcium released from the bones into the blood is increased. Aredia belongs to a group of medicines called bisphosphonates, which strongly bind to bone. These medicines slow down the rate of bone change and help to restore the amount of calcium in the blood to normal.
Aredia can also be used in other conditions with increased bone changes or pain, including Paget's disease, advanced cancer of the bone marrow (called multiple myeloma) and advanced breast cancer where the cancer has spread to the bone from other parts of the body (called metastases).
Ask your doctor if you have any questions about why this medicine has been
prescribed for you.
Your doctor may have prescribed it for another purpose.
Aredia is only available with a doctor's prescription. It is not addictive.
There is not enough information to recommend the use of this medicine in children.
Do not have Aredia if you have ever had an allergic reaction to:
Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin.
If you are not sure whether you are allergic to other bisphosphonate
medicines, talk to your doctor.
Other bisphosphonate medicines can cause breathing difficulties in people with
asthma who are allergic to aspirin.
Do not have Aredia after the expiry date printed on the pack or if the
packaging is torn or shows signs of tampering.
In that case, return the medicine to your pharmacist.
Tell your doctor if you are pregnant or planning to become pregnant.
There is no information on use of this medicine in pregnancy. Your doctor can
discuss with you the benefits and risks involved.
Tell your doctor if you are breast-feeding.
Breast-feeding is not recommended while you are having Aredia. It is not known
if the active ingredient, disodium pamidronate, passes into the breast milk and
could affect your baby.
Tell your doctor if:
Your doctor may want to take special precautions if you have any of the above conditions.
Tell your doctor if you are taking any other medicines, including
medicines that you buy without a prescription from a pharmacy, supermarket or
health food shop.
Some medicines and Aredia may interfere with each other. These include:
You may need to take different amounts of your medicines or you may need to take different medicines. Your doctor and pharmacist have more information.
If you have not told your doctor about any of these things, tell him/her before you have Aredia.
Aredia will be given by slow intravenous infusion into a vein. The dry powder in the vial is dissolved in sterile water and then put into an intravenous drip. An infusion may last several hours, depending on the dose given and whether or not you have kidney problems.
You may also be given an infusion of fluids to ensure that you do not become dehydrated.
The dose is usually between 30 mg and 90 mg, depending on the condition being treated.
The need for more doses will depend on how well your body responds to the treatment. If you have cancer in the bone you will usually receive a dose every 4 weeks. But if you are having chemotherapy every 3 weeks, Aredia can be given at the same time.
Since bisphosphonate medicines may cause damage to the kidneys, you will have a blood test before each dose to make sure this medicine is not affecting your kidneys.
Tell your doctor if you have any of the following symptoms. They may mean that the level of calcium in your blood has fallen too far.
Follow your doctor's instructions carefully and keep all appointments.
You will need regular blood tests to make sure the treatment is working. In the
early stages of treatment for high blood calcium, these tests may be done
several times a day. Regular blood tests can also find side effects before they
become serious.
Tell your doctor immediately if you become pregnant while having treatment
with Aredia.
Your doctor can discuss with you the risks of having it while you are pregnant.
If you are about to be started on any new medicine, remind your doctor and pharmacist that you are having Aredia.
Tell any other doctor, dentist or pharmacist who treats you that you are having Aredia.
Do not give this medicine to anyone else even if their symptoms seem to be the same as yours.
Do not use it to treat any other complaints unless your doctor tells you to.
Be careful driving, operating machinery or doing jobs that require you to
be alert after you have a dose of Aredia until you know how it affects you. If
you are returning home immediately after the infusion, arrange to have someone
else drive.
This medicine may cause dizziness or sleepiness in some people, especially right
after the infusion. It usually does not last longer than 24 hours.
Tell your doctor or pharmacist as soon as possible if you do not feel well
while you are having Aredia.
All medicines can have side effects. Sometimes they are serious, most of the
time they are not. You may need medical treatment if you get some of the side
effects. If you are over 65 and you have a serious heart or kidney problem,
you may be more likely to have unwanted effects from your treatment.
Do not be alarmed by these lists of possible side effects. You may not experience any of them. Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor if you notice any of the following side effects and they worry you:
Tell your doctor immediately or go to the Accident and Emergency Department at your nearest hospital if you notice any of the following:
The above side effects may be serious. You may need urgent medical attention.
Tell your doctor if you notice anything else that is making you feel
unwell.
Some people may have other side effects not yet known or mentioned in this
leaflet. Some side effects can only be found by laboratory testing.
If you are keeping a supply of Aredia at home:
Keep the medicine where young children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good
place to store medicines.
If you no longer need Aredia or it has passed its expiry date, return any unused medicine to your pharmacist.
Aredia is packaged in glass vials containing the active ingredient, disodium pamidronate, in a dry powder form. An ampoule containing water for injections is provided for use in dissolving the powder.
Aredia vials contain 30 mg of disodium pamidronate. The vials also contain mannitol and phosphoric acid.
Aredia is supplied in New Zealand by:
Novartis New Zealand Limited
Private Bag 19 999
43-45 Patiki Road
Avondale
AUCKLAND
Telephone: 0800 652 422
® = Registered Trademark
This leaflet was prepared on the 8th of February 2005 based on the currently approved data sheet for this product.